RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 128 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,522 | -85.6% | 110 | -89.7% | 0.00% | – |
| Q2 2023 | $17,529 | +2082.9% | 1,063 | +2262.2% | 0.00% | – |
| Q1 2023 | $803 | -38.7% | 45 | 0.0% | 0.00% | – |
| Q4 2022 | $1,310 | +31.0% | 45 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 45 | -65.4% | 0.00% | – |
| Q1 2022 | $1,000 | -96.9% | 130 | -95.9% | 0.00% | – |
| Q4 2021 | $32,000 | +3100.0% | 3,164 | +3195.8% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 96 | -29.4% | 0.00% | – |
| Q2 2021 | $3,000 | -72.7% | 136 | -72.5% | 0.00% | – |
| Q1 2021 | $11,000 | -56.0% | 494 | -40.4% | 0.00% | – |
| Q4 2020 | $25,000 | +150.0% | 829 | +79.8% | 0.00% | – |
| Q3 2020 | $10,000 | +400.0% | 461 | +339.0% | 0.00% | – |
| Q2 2020 | $2,000 | -33.3% | 105 | +6.1% | 0.00% | – |
| Q1 2019 | $3,000 | – | 99 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |